Cellectis ROIC
Qual é o ROIC de Cellectis?
O ROIC de Cellectis é -32.59%
Qual é a definição de ROIC?
Return on invested capital (ROIC) is a financial ratio that measures how efficient a company is at allocating the capital under its control to profitable investments.
= NOPAT / Invested capital = EBIT * (1 - tax rate) / (2-year average liabilities + 2-year average shareholder equity)
Return on invested capital (ROIC) ratio gives investors a sense of how well a company is using money under its control to generate profitable returns.
ROIC can be used as a benchmark to calculate the valuation of companies across industries. A higher ROIC means the company is doing a better job of investing the money from shareholders and bondholders to run the business. A company is creating value if its ROIC exceeds 2%. If its ROIC is under 2%, the company is likely destroying value and has no excess capital to invest in future growth.
You can calculate ROIC with the following formula:
NOPAT = Net operating profit after tax
Invested Capital = Average total liabilities + Average shareholders' equity
The averages of liabilities and shareholders' equity are calculated as geometrical averages of the last two annual values from the company's balance sheet.
ROIC de empresas na Setor Health Care em NASDAQ em comparação com Cellectis
O que Cellectis faz?
cellectis is a clinical-stage biopharmaceutical company focused on developing a new generation of cancer immunotherapies based on gene-edited t-cells (ucart). by capitalizing on its 18 years of expertise in gene editing – built on its flagship talen® technology and pioneering electroporation system pulseagile – cellectis uses the power of the immune system to target and eradicate cancer cells. using its life-science-focused, pioneering genome engineering technologies, cellectis’ goal is to create innovative products in multiple fields and with various target markets. cellectis is listed on the nasdaq market (ticker: clls) and on the nyse alternext market (ticker: alcls). to find out more about us, visit our website: www.cellectis.com talking about gene editing? we do it. talen® is a registered trademark owned by the cellectis group.
Empresas com roic semelhantes a Cellectis
- Avesoro Resources tem ROIC de -32.77%
- Pharmadrug tem ROIC de -32.75%
- Five Prime Therapeutics Inc tem ROIC de -32.73%
- Electreon Wireless Ltd tem ROIC de -32.68%
- Xenetic Biosciences Inc tem ROIC de -32.65%
- Miniluxe Corp tem ROIC de -32.64%
- Cellectis tem ROIC de -32.59%
- Sonoma Pharmaceuticals tem ROIC de -32.49%
- Contact Gold tem ROIC de -32.49%
- Apache tem ROIC de -32.48%
- CHAR Technologies tem ROIC de -32.46%
- Fangdd Network Ltd tem ROIC de -32.43%
- Golden Independence Mining tem ROIC de -32.42%